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Background: Previous studies of nonclinical samples
exhibiting schizotypal traits have provided support for
the existence of a continuous distribution of psychotic
symptoms in the general population. Few studies, however, have examined the neural correlates of psychometric
schizotypy using structural and diffusion tensor imaging
(DTI). Methods: Healthy volunteers between the ages
of 18 and 68 were recruited from the community and
assessed using the Schizotypal Personality Questionnaire
and received structural and DTI exams. Participants with
high (N = 67) and low (N = 71) psychometric schizotypy
were compared on gray and white matter volume, and cortical thickness in frontal and temporal lobe regions and on
fractional anisotropy (FA) within 5 association tracts traversing the frontal and temporal lobes. Results: Higher
levels of schizotypy were associated with lower overall
volumes of gray matter in both the frontal and temporal
lobes and lower gray matter thickness in the temporal
lobe. Regionally specific effects were evident in both white
matter and gray matter volume of the rostral middle frontal cortex and gray matter volume in the pars orbitalis.
Moreover, relative to individuals who scored low, those
who scored high in schizotypy had lower FA in the inferior
fronto-occipital fasciculus as well as greater asymmetry
(right > left) in the uncinate fasciculus. Conclusions:
These findings are broadly consistent with recent data on
the neurobiological correlates of psychometric schizotypy
as well as findings in schizotypal personality disorder and
schizophrenia and suggest that frontotemporal lobe dysfunction may represent a core component of the psychosis
phenotype.

Introduction
Large-scale genome-wide association studies1,2 have provided strong evidence that the etiology of schizophrenia
(SZ) is complex and multifactorial. Moreover, such studies have demonstrated that hundreds to thousands of
common genetic variants with small effects contribute to
the behavioral expression of psychotic-like phenomena
across traditional diagnostic boundaries.3 Such findings
provide strong support for a dimensional model in which
phenomenological, genetic, and cognitive factors interact to affect the behavioral expression and severity of
psychotic symptoms.4 At the phenotypic level, evidence
suggests the existence of a continuous distribution of psychotic symptoms in the general population ranging from
mild, or subclinical, to severe and clinically significant,
with additional evidence indicating etiological continuity
between subclinical and clinically significant psychosis
phenotypes.5 The continuity between subclinical psychosis at the population level and the clinically significant
levels of psychosis observed in SZ spectrum disorders
may provide a unique opportunity to elucidate the pathophysiology of psychotic disorders free of the potentially
confounding effects of treatment-related factors.
Although several approaches have been employed to
measure subclinical psychosis in nontreatment seeking
populations, the measurement of schizotypal traits is
among the most common.6 Schizotypy was initially conceptualized by Rado7, and later elaborated by Meehl8,9,
to denote the genetically determined predisposition to
SZ and may be measured in nonclinical samples using
psychometric self-report questionnaires such as the
Schizotypal Personality Questionnaire (SPQ)10 or the
Chapman Scales.11 Studies have generally demonstrated
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schizotypy to have dimensional factor structures analogous to those observed in SZ.12–14 Moreover, several independent studies15–18 have shown an increased incidence
of schizotypy in relatives of SZ patients that are likely
related to shared genetic variation.19,20 Thus, the examination of psychometric schizotypy within nonpsychiatric
populations is ideally suited for studies seeking to better
characterize the neurobiology of psychosis.21
Several studies have examined the neurobiological
basis of schizotypal personality disorder (SPD), a disorder characterized by severe schizotypal traits including
asocial tendencies, difficulties with language, paranoia,
odd behavior, and magical thinking. Recent reviews22–24
suggest that at the structural level, SPD is associated
with temporal lobe abnormalities comparable to those
observed in SZ while frontal lobe regions may be more
spared. Moreover, the aforementioned reviews also suggest that low fractional anisotropy (FA), a measure
broadly associated with white matter integrity, in the uncinate fasciculus (UF) and temporal lobe is present in SPD;
a finding generally consistent with those observed in SZ.25
To date, however, relatively few studies have examined the
neurobiological basis of psychometric schizotypy, or subclinical psychosis, in otherwise healthy adults.
Although several studies have reported structural differences between healthy participants with high levels of
subclinical positive symptoms vs low levels, overall findings have been mixed.26–28 However, several studies have
reported cortical thickness abnormalities among healthy
individuals with high levels of schizotypy compared with
low levels29,30 that are broadly consistent with findings in
SZ patient samples.31 Additionally, diffusion tensor imaging (DTI) studies have provided complementary evidence
for white matter alterations in psychometrically defined
schizotypy similar to those observed in SZ, but these
findings have also been inconsistent. While some studies
have found higher FA in some regions but lower FA in
others,32 others have found consistent reductions in FA in
several regions33,34 and yet others have found increases in
FA35 related to high levels of subclinical psychotic symptoms. Taken together these studies implicate aberrant
neurodevelopmental processes in subclinical psychosis
that are similar to those believed to underlie the neurobiology of SZ without the associated confound of antipsychotic medications and suggest that the examination of
psychometric schizotypy in nonpsychiatric populations
may provide insight into the neurobiology of psychosis.
Samples examined in prior work, however, have been relatively small and have not comprehensively assessed the
brain using multimodal imaging. Moreover, several prior
studies examined adolescent and young adult samples
that may still be at risk for developing psychosis. In the
present study, we thus investigated both gray and white
matter structural variation in relation to psychometric
schizotypy using structural and DTI in a large sample of
healthy adults. Consistent with observations of less gray

matter volume in SZ36 and with models of frontotemporal lobe dysfunction in SZ,37–39 we hypothesized that
individuals characterized by high schizotypy would demonstrate less gray matter volume, lower cortical thickness,
and lower FA in frontal and temporal lobe regions, compared with those characterized by low schizotypy.
Methods
Participants
The present sample comprised 138 (72 M/66 F) healthy volunteers ages 18–68 (Meanage = 35.69 ± 13.02). Participants
were recruited from the general population via word
of mouth, newspaper and internet advertisements, and
posted fliers for an National Institute of Mental Healthfunded study of subclinical psychosis (MH086756 to
P.D.). Participation in the imaging component of the study
was optional. A total of 38 additional participants were
screened for participation in the present study but were not
included because they met one or more exclusion criteria.
Exclusion criteria included having a first-degree family
member with a psychotic illness, present or past psychotic
or affective disorder diagnosis as determined by clinical
interview using the nonpatient edition of the Structured
Clinical Interview for the DSM-IV, Non-Patient edition
(SCIDI-N/P),40 evidence of an intellectual disability (operationally defined as a Wide Range Achievement Test-Third
Edition-Reading Subtest [WRAT-3] reading score of <70),
active or recent substance abuse (as assessed by urine toxicology testing), magnetic resonance imaging (MRI) contraindications (eg, pacemaker, internal defibrillator, infusion
pump, insulin pump, cochlear implant, hearing aid, iron/
steel on or in the body), pregnancy, or significant medical
illness as determined by a medical history questionnaire.
This study was approved by the North Shore-Long Island
Jewish Health System Institutional Review Board and all
participants provided written, informed consent.
Clinical Assessments
All assessments were conducted by Master’s or PhD level
clinicians or psychometicians who have extensive training
in the administration of clinical and cognitive assessments.
Diagnostic Assessments. Participants were initially administered the SCIDI-N/P40 to rule out a past or present affective or psychotic disorder. Information obtained from the
SCID was compiled into a narrative case summary and presented to 2 senior members of the Zucker Hillside Hospital
clinical faculty. Absence of pathology was determined by
consensus after the presentation of the narrative case summary and discussion of any relevant symptomatology.
Psychometric Schizotypy. To assess schizotypal symptom severity we utilized the SPQ,10 which is a well-validated, 74-item, self-report questionnaire. The SPQ
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provides an overall measure of psychometric schizotypy
that includes 9 dimensions, each reflecting a criterion
for DSM-IV schizotypal personality disorder, including
ideas of reference, excessive social anxiety, odd beliefs or
magical thinking, unusual perceptual experiences, odd
or eccentric behavior, no close friends, odd speech, constricted affect, and suspiciousness.
Estimated IQ. We utilized the WRAT-3 as an estimate
of IQ. The WRAT-3 is a test that assesses single word
reading skill and is highly correlated with full scale IQ.41
Handedness. All individuals were classified as either
right or left-handed based on a modified version of the
Edinburgh Inventory. The total number of right and left
hand items was scored and the laterality quotient was
computed according to the following formula: (Total R −
Total L)/(Total R + Total L) yielding a range from +1.00
(totally dextral) to −1.00 (totally nondextral).
Magnetic Resonance Imaging
Image Acquisition. MRI exams were conducted at
the North Shore University Medical Center on a GE
3T Signa HDx, whole body superconducting imaging
system. A radiologist reviewed all scans for gross anatomic pathology that would preclude participation in
this study. We minimized movement by stabilizing the
head with cushions prior to scanning. We acquired 3D
spoiled gradient images using a 1-mm thick slice acquisition with the following image parameters: repetition time
(TR) = 7.5 ms, echo time (TE) = 3 ms, matrix = 256 × 256,
field of view (FOV) = 240 mm, 216 contiguous images.
We also acquired DTI data using a total of 36 DTI volumes from each subject, including 31 volumes with diffusion gradients applied along 31 nonparallel directions
with b = 1000 s/mm2 and, and 5 volumes without diffusion weighting (b = 0 s/mm2). Each volume consisted of
51 contiguous 2.5-mm axial slices acquired parallel to
the anterior-posterior commissural line using a ramp
sampled, spin-echo, single-shot echoplanar imaging
method (TR = 1400 ms, TE = min, matrix = 128 × 128,
FOV = 240 mm).
Structural Imaging Methods. Cortical reconstruction and volumetric segmentation was performed using
Freesurfer image analysis software (version 5.0.0), which
is documented and freely available online (http://surfer.
nmr.mgh.harvard.edu). Technical details of these procedures are described in prior publications.42–44 Processing
includes motion correction, removal of non-brain tissue,45
automated Talairach transformation, segmentation of the
subcortical regions and deep gray matter structures43 intensity normalization,46 tessellation of the gray matter-white
matter boundary, automated topology correction,47,48 and
surface deformation following intensity gradients.49 Gray
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matter volume, white matter volume, and cortical thickness measures were computed and subsequently assigned
to either the frontal or temporal lobes. Individual regions
comprising the frontal (N = 11) and temporal (N = 9)
lobes were determined a priori based on prior work.50 The
frontal lobe included the superior frontal, rostral middle
frontal, caudal middle frontal, pars opercularis, pars triangularis, pars orbitalis, lateral orbital frontal, medial
orbital frontal, precentral, paracentral, and frontal pole
regions. The temporal lobe included the superior temporal, middle temporal, inferior temporal, banks of the
superior temporal sulcus, fusiform gyrus, transverse temporal, entorhinal, temporal pole, and parahippocampal
regions. These regions are illustrated in figure 1.
DTI Methods and Tractography. Image processing was
conducted using the Functional Magnetic Resonance
Imaging of the Brain Software Library (FSL; http://fsl.
fmrib.ox.ac.uk/fsl/). Eddy-current induced distortions and
head-motion displacements were corrected through affine
registration of the 31 diffusion volumes to the first b0 volume using FSL’s Linear Registration Tool (FLIRT).51 The
b-vector table (ie, gradient directions) for each participant
was then adjusted according to the rotation parameters of
this linear correction. Non-brain tissue was removed using
FSL’s Brain Extraction Tool. FA was then calculated at
each voxel of the brain by fitting a diffusion tensor model
to the raw diffusion data using weighted least squares in
FSL’s Diffusion Toolbox.
FA within 5 association tracts traversing the frontal
and temporal lobes were assessed, including the inferior
fronto-occipital fasciculus (IFOF), inferior longitudinal
fasciculus (ILF), cingulum bundle, superior longitudinal
fasciculus (SLF), and UF. These tracts are illustrated in
figure 2. Detailed delineation criteria regarding the individual tracts are provided in our prior study.52 Withinvoxel probability density functions of the principal
diffusion direction were estimated using Markov Chain
Monte Carlo sampling in FSL’s BEDPOSTX tool.53
A spatial probability density function was then estimated
across voxels based on these local probability density
functions using FSL’s PROBTRACKX tool,53 in which
5000 samples were taken for each input voxel with a 0.2
curvature threshold, 0.5-mm step length, and 2000 steps
per sample. For each tract, seed masks, way-points, termination, and exclusion masks were defined on the MNI152
T1 1-mm template. Masks were normalized to each subjects’ diffusion space using FLIRT,51 applying the affine
parameters obtained by coregistering the first b0 volume
to the MNI152 1-mm T1 brain. The resulting tracts were
thresholded at a normalized probability value.
Statistical Analysis
In all analyses, the distribution of the dependent measures was first inspected to ensure normality. Although

Psychometric Schizotypy

Fig. 1. Freesurfer segmentation of fronto-temporal regions examined in the present study for association to psychometric schizotypy.

Fig. 2. Five association tracts traversing the frontal and temporal lobes examined in the present study for association to psychometric schizotypy.
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we initially considered using the SPQ Total score as a
continuous measure in regression models, this approach
was not statistically valid because neither the SPQ scores,
nor the residuals produced by the regression models,
were normally distributed. Therefore, we dichotomized
the sample, using a median split, into those who scored
higher (high schizotypy: N = 67) and those who scored
lower (low schizotypy: N = 71) on the SPQ.
Initially, group differences in demographic characteristics were assessed using independent group’s t tests or
chi-square tests. Repeated measures ANCOVA was used
to assess group differences in brain structure volume and
thickness, and FA within tracts. In brain structure volume and cortical thickness analyses, group served as the
between-subjects factor. We summed right and left hemisphere volumes for gray matter and white matter structures, respectively and averaged right and left cortical
thickness given the lack of group × hemisphere interactions for these measures. Gray matter volume, white matter
volume, and cortical thickness served as the within-subjects factors in separate analyses investigating the frontal and temporal lobes. We used the Greenhouse-Geisser
correction in these analyses given that the Mauchly’s test
of sphericity was significant. There were significant group
by hemisphere effects for the FA measures and thus, we
did not average these measures for subsequent analyses.
Thus, hemisphere served as a within-subjects factor in FA
analyses, which were conducted separately by tract given
their functional and neuroanatomical heterogeneity.52
In all analyses, age, sex, and intracranial volume were
included as covariates. Alpha was set to .05 and all analyses were 2 tailed.
Results
Comparison of high vs low schizotypy groups on the
total SPQ score confirmed that the groups significantly
differed (MHigh = 8.52 ± 6.66 vs MLow = 0.75 ± 0.82; t =
9.49; P < .001). Moreover, the relatively low mean of the
high schizotypy group suggested symptom levels were
reflective of subclinical psychometric schizotypy rather
than schizotypal personality disorder. Comparison of
high and low schizotypy groups on additional demographic characteristics revealed no significant differences
(all P’s > .05) in age (MHigh = 36.17 ± 13.93 vs MLow =
35.23 ± 12.18), estimated IQ (MHigh = 101.91 ± 11.09 vs
MLow = 101.39 ± 9.80), or handedness (MHigh = 0.77 ±
0.50 vs MLow=0.80 ± 0.38). Examination of sex distributions revealed that the proportion of females in the high
schizotypy group (56.72%) was significantly greater than
in the low schizotypy group (39.44%) (χ2 = 4.13, P = .04).
Mean (SD) values for the frontal and temporal lobe
white matter and gray matter volumes are provided in
table 1 with univariate analyses provided for descriptive purposes only. In the primary repeated measures
ANCOVA, there were significant main effects of group
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for both frontal (F(1,133) = 4.50, P = .036) and temporal
(F(1,133) = 4.40, P = .038) gray matter volumes such that
high schizotypy individuals had less volume overall compared with low schizotypy individuals. There were also
significant group × region interactions for frontal white
(F(1,133) = 2.40, P = .049) and gray (F(1,133) = 3.89, P = .003)
matter volume. Post-hoc analysis indicated lower volumes of white matter in the rostral middle frontal cortex (F(1,133) = 3.95, P = .049), gray matter pars orbitalis
(F(1,133) = 4.06, P = .046), and gray matter rostral middle
frontal cortex (F(1,133) = 8.15, P = .005) in high schizotypy
participants compared with low schizotypy participants.
No main effects of group were observed for frontal or
temporal white matter volume. There was a significant
main effect of group for temporal gray matter thickness
(F(1,133) = 4.40, P = .038), but not for frontal gray matter thickness. Specifically, high schizotypy participants
exhibited lower gray matter thickness compared with
low schizotypy participants. The group-by-region interactions were not statistically significant for gray matter
thickness in either the frontal or temporal lobes (P’s >
.05). The frontal and temporal lobe gray matter thickness
measures are provided in table 2 with univariate analyses
provided for descriptive purposes only.
Analysis of FA using the tract-based measures revealed
a significant main effect of group for the IFOF (F(1,133)
= 4.90, P = .029) such that high schizotypy individuals
had lower FA compared with low schizotypy individuals.
In addition, there was a significant group × hemisphere
interaction for the UF (F(1,133) = 6.29, 133, P = .013). Posthoc analysis revealed that high schizotypy individuals
had significantly greater asymmetry (R > L; t(136) = −2.78,
P = .006) in the UF compared with low schizotypy individuals. There were no significant group differences in FA
in either the right or left UF. Neither the main effects of
group nor group-by-hemisphere interactions were statistically significant for the SLF, ILF, or cingulum bundle. Mean (SD) FA values for the tracts are provided in
table 3 with univariate analyses provided for descriptive
purposes only.
To determine whether having both volume and thickness abnormalities was associated with greater psychometric schizotypy, we conducted 3 supplementary
logistic regression analyses to predict group membership
for regions that differed significantly between groups
including gray matter volume (rostral middle frontal and
pars orbitalis), white matter volume (rostral middle frontal), and average temporal lobe gray matter thickness.
Classes of regions (gray matter, white matter, and thickness) were entered into the logistic regression in blocks
to determine whether the overall model improved significantly by adding the last block. Thus, as an example,
in one logistic regression gray matter and white matter
volumes were entered into the model as the first block
followed by temporal gray matter thickness in the second block to determine whether the addition of the latter

12 543 (1954)
533 (113)
13 259 (1939)
7126 (1393)
26 637 (3710)
2074 (379)
7107 (1457)
6494 (1122)
25 530(4132)
35 842 (5431)
8318 (1365)
1327 (217)
14 032 (2268)
11 487 (1833)
11 772 (2019)
1540 (402)
3307 (491)
13 179 (2053)
5711 (1045)
1424 (227)

13 230 (2217)

546 (114)
13 903 (1576)

7588 (1245)

27 362 (3503)
2164 (280)
7196 (1239)
6713 (878)
27 440 (3546)

37 816 (4209)
8590 (1125)

1384 (204)
14 562 (1872)

11 847 (1450)
12 156 (1637)
1587 (351)
3521 (453)
13 605 (1801)
5779 (891)

1431 (203)

−89 to 39

−400 to 321
−508 to 345
−123 to 91
−3 to 253
−488 to 440
−381 to 162

−45 to 78
−431 to 456

−157 to 1891
−287 to 393

−933 to 763
−70 to 86
−559 to 99
−230 to 229
4 to 1888

−153 to 463

−34 to 42
−170 to 598

−220 to 860

Mean (SD)

.32 11 329 (1487)

.83 1963 (288)
.27 16 685 (1732)

.24 14 185 (2427)

P

0.60

0.05
0.14
0.09
3.73
0.01
0.64

0.28
0.01

2.80
0.10

.44

2172 (391)

.83 25 354 (3104)
.71 23 280 (3191)
.77 4203 (720)
.06 4730 (516)
.92 21 668 (2584)
.43 5325 (738)

.60 5210 (608)
.95 25 175 (2778)

.10 48 954 (4727)
.758 7840 (946)

0.04 .84 28 722 (3285)
0.04 .84 5550 (718)
1.91 .17 9610 (1461)
0.07 .79 8828 (1313)
3.95 <.05 36 893 (4552)

0.99

0.04
1.21

1.38

95% CIa, Low to High F

Note: df = 138. SPQ, Schizotypal Personality Questionnaire.
a
Adjusted for age, sex, and intracranial volume. Analyses are presented for descriptive purposes only.

Frontal
Caudal middle
frontal
Frontal pole
Lateral
orbitofrontal
Medial
orbitofrontal
Precentral
Pars orbitalis
Pars opercularis
Pars triangularis
Rostral middle
frontal
Superior frontal
Paracentral
Temporal
Temporal pole
Superior
temporal
Middle temporal
Inferior temporal
Entorhinal
Parahippocampal
Fusiform
Banks of superior
temporal sulcus
Transverse

Mean (SD)

2088 (346)

24 092 (3274)
22 772 (3221)
3955 (591)
4489 (607)
20 523 (2580)
5196 (835)

5161 (563)
24 202 (2995)

46 567 (6011)
7548 (1091)

27 526 (3246)
5191 (771)
9572 (1729)
8658 (1388)
34 147 (5074)

10 822 (1459)

1972 (312)
15 972 (1966)

13 476 (2333)

Mean (SD)

Low SPQ (N = 71) High SPQ (N = 67)

Low SPQ (N = 71) High SPQ (N = 67)

Mean (SD)

Gray Matter

White Matter

Table 1. Average Frontal and Temporal Gray Matter Volumes (mm3) for Healthy Individuals With High and Low Psychometric Schizotypy

−90 to 127

−301 to 1185
−1080 to 543
−74 to 320
2 to 342
−165 to 1207
−251 to 148

−224 to 159
−395 to 920

−23 to 2248
−133 to 416

−387 to 1252
4 to 438
−707 to 66
−476 to 281
512 to 2823

−234 to 493

−125 to 76
−146 to 644

−345 to 878

0.12

1.39
0.43
1.52
4.00
2.26
0.26

0.11
0.62

3.754
1.04

1.09
4.06
2.64
0.26
8.15

0.50

0.24
1.55

0.74

95% CIa, Low to High F

.74

.24
.51
.22
<.05
.14
.61

.74
.43

.06
.31

.30
<.05
.11
.61
.01

.48

.63
.23

.39

P
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Table 2. Average Frontal and Temporal Cortical Thickness for Individuals With High and Low Psychometric Schizotypy
Low SPQ
(N = 71)

Frontal cortical thickness
Caudal middle frontal
Frontal pole
Lateral orbitofrontal
Medial orbitofrontal
Precentral
Pars orbitalis
Pars opercularis
Pars triangularis
Rostral middle frontal
Superior frontal
Paracentral
Temporal cortical thickness
Temporal pole
Superior temporal
Middle temporal
Inferior temporal
Entorhinal
Parahippocampal
Fusiform
Banks of the superior temporal sulcus
Transverse

High SPQ
(N = 67)

Mean

(SD)

Mean

(SD)

95% CIa, Low to
High

2.62
2.89
2.62
2.36
2.60
2.83
2.63
2.54
2.42
2.75
2.44

0.14
0.22
0.12
0.13
0.10
0.17
0.13
0.13
0.12
0.13
0.10

2.30
2.85
2.61
2.37
2.56
2.78
2.61
2.54
2.40
2.74
2.41

0.13
0.22
0.15
0.12
0.11
0.17
0.11
0.14
0.12
0.12
0.11

−0.02 to 0.06
−0.04 to 0.11
−0.02 to 0.06
−0.06 to 0.03
−0.003 to 0.06
−0.01 to 0.10
−0.03 to 0.04
−0.05 to 0.04
−0.02 to 0.05
−0.02 to 0.05
−0.01 to 0.06

0.87
0.99
0.68
0.49
3.26
2.78
0.05
0.01
0.69
0.55
2.36

.35
.32
.41
.49
.07
.10
.83
.93
.41
.46
.13

3.81
2.83
2.96
2.88
3.68
2.76
2.77
2.54
2.45

0.26
0.13
0.13
0.12
0.27
0.25
0.12
0.13
0.15

3.82
2.78
2.93
2.86
3.55
2.73
2.73
2.52
2.42

0.26
0.12
0.13
0.13
0.28
0.27
0.12
0.12
0.17

−0.108 to 0.073
0.003 to 0.083
−0.007 to 0.073
−0.015 to 0.064
0.034 to 0.225
−0.036 to 0.132
0.004 to 0.077
−0.023 to 0.054
−0.029 to 0.075

0.14
4.54
2.73
1.52
7.16
1.29
4.77
0.63
0.76

.71
.04
.10
.22
.01
.26
.03
.43
.38

F

P

Note: df = 138. SPQ, Schizotypal Personality Questionnaire.
a
Adjusted for age, sex, and intracranial volume. Analyses are presented for descriptive purposes only.
Table 3. Average Fractional Anisotropy Values for Healthy Individuals With High and Low Psychometric Schizotypy
Low SPQ (N = 71)

High SPQ (N = 67)

Mean

(SD)

Mean

(SD)

95% CIa

F

P

0.051
0.046

0.557
0.535

0.044
0.050

−0.015 to 0.015
−0.02 to 0.013

0.001
0.16

.98
.69

0.026
0.026

0.536
0.532

0.024
0.024

0.0003 to 0.015
0.001 to 0.017

4.21
4.66

.04
.03

0.035
0.039

0.557
0.545

0.034
0.031

−0.006 to 0.017
−0.008 to 0.016

0.87
0.46

.35
.50

0.036
0.03.

0.513
0.520

0.037
0.032

−0.01 to 0.015
−0.012 to 0.01

0.14
0.03

.71
.86

0.0329
0.0345

0.504
0.534

0.032
0.032

−0.007 to 0.016
−0.019 to 0.004

0.58
1.75

.45
.19

Fractional anisotropy (FA)
Cingulum
Left
0.563
Right
0.533
Inferior fronto-occipital fasciculus
Left
0.546
Right
0.542
Inferior longitudinal fasciculus
Left
0.565
Right
0.552
Superior longitudinal fasciculus
Left
0.518
Right
0.521
Uncinate fasciculus
Left
0.510
Right
0.527

Note: df = 138. SPQ, Schizotypal Personality Questionnaire.
a
Adjusted for age, sex, and intracranial volume. Analyses are presented for descriptive purposes only.

variable significantly improved the overall model. None
of the regression models were significant (P > .05) suggesting that no particular abnormality predicted group
membership above and beyond the others.
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Supplementary ANCOVA were conducted using 3
groups (low, medium, and high psychometric schizotypy) in contrast to the median split approach to further
examine the relationship between subclinical symptoms
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and our imaging measures; these analyses yielded results
consistent with our original findings. Moreover, the most
robust effects were identified between individuals with the
highest SPQ total scores compared with the other groups.
Specifically, patients with the highest SPQ total scores
had significantly (P < .05) lower FA within the IFOF,
less total gray and white matter in the rostral middle
frontal gyrus, lower average temporal thickness, and less
total gray matter in the pars orbitalis compared with the
other 2 groups. Trend level effects (P = .08) for a group×-hemisphere interaction (likely reflecting the lower statistical power) were evident for asymmetry within the UF
such that individuals with the highest total SPQ total
scores demonstrated greater asymmetry compared with
the other groups.
Although we used sex as a covariate in our analyses, we
conducted ancillary analyses by removing the 10 youngest males with low total schizotypy scores from the analysis to better match the groups for sex, which served to
equate the sex distribution across groups (P = .22) while
maintaining the age match, and reran all of our primary
analyses. The group main effects for FA in the IFOF, UF
FA asymmetry, rostral middle frontal white and gray
matter volume, and pars orbitalis gray matter volume all
remained statistically significant (Ps > .05).
Discussion
The results of this investigation indicated an association between psychometric schizotypy and measures of
gray and white matter using both structural and DTI.
Specifically, our study indicated that otherwise healthy
adults who exhibit higher levels of psychometric schizotypy demonstrated less frontal and temporal lobe gray
matter and lower temporal lobe gray matter thickness
compared with participants characterized as lower in
schizotypy. Regionally specific effects were also evident
such that individuals characterized as higher in psychometric schizotypy had less gray and white matter volume specifically within the rostral middle frontal region
compared with individuals characterized as lower in
schizotypy. Investigation of cortical thickness measures
indicated that individuals higher in schizotypy demonstrated lower temporal (but not frontal) cortical thickness compared with individuals lower in schizotypy.
Moreover, the use of probabilistic tractography indicated
that compared with individuals characterized as lower in
psychometric schizotypy, those who were characterized
as higher in schizotypy had lower FA in the IFOF as well
as differences in UF asymmetry. Strengths of the current study include the large sample, comprised of healthy
adults with no history of an Axis I disorder, and no history of psychotropic medication exposure and the use of
multimodal imaging measures.
It is difficult to compare our findings to prior work
given that few studies have investigated psychometric

schizotypy, especially across a broad range of imaging
measures. Our findings are generally consistent, however, with recent data suggesting that high levels of positive schizotypy in otherwise healthy adults is associated
with significantly less gray matter volume in medial prefrontal, orbitofrontal, and temporal cortical regions.28
Our findings also converge with prior work in patients
with SZ54 and SPD,24 which identified less gray matter in
frontal and temporal lobe regions. Moreover, our study
identified less gray and white matter that was localized
to the rostral middle frontal cortex among individuals
higher in psychometric schizotypy compared with those
lower in schizotypy. Consistent with our findings, several
prior neuroimaging studies in SZ reported less gray55
and white56 matter in the rostral middle frontal region
and thus, dysfunction involving this region may be particularly relevant for the overlap in phenotypic expression
between SZ and schizotypy. It is also noteworthy that
dysfunction within the rostral middle frontal region may
contribute to abnormal executive functioning,57 a cognitive domain that is impaired in both SZ58 and SPD.59
Prior work reported that compared with patients with
SZ, patients with SPD may demonstrate preservation of
some frontal lobe white matter regions60,61 that could,
at least in part, reflect a compensatory mechanism. In
contrast, temporal gray matter abnormalities may be a
feature shared by both patients with SZ and SPD. This
hypothesis is consistent with volumetric findings from
the current study wherein a main effect of group was not
apparent for frontal lobe white matter volume in contrast to the gray matter where a main effect of group was
observed. This suggests white matter volume at the gross
anatomic level in the frontal (perhaps except for the rostral middle frontal region) could conceivably be protective for higher levels of psychometric schizotypy and is
consistent with the hypothesis that different subregions
within the frontal cortex may differentiate SZ from SPD.
In addition, neither global nor regionally specific effects
were evident between groups in frontal cortical thickness further implicating an additional possible protective
mechanism from frank psychosis. It should be noted that
while gray matter volume and cortical thickness share
similar properties, they are fundamentally different measures.62,63 For example, although both thickness and area
can influence volume, volume may be more closely associated with surface area than cortical thickness,64 which
appears to be specifically influenced by cell type and/or
neuronal density.65
Our finding of lower FA within the IFOF among individuals higher in psychometric schizotypy is consistent
with prior work implicating dysfunction of this tract in
the neurobiology of SZ. For example, Yao et al66 reported
white matter deficits in first-episode SZ in the left IFOF
using an activation likelihood estimation meta-analysis
involving 8 studies that included 271 first-episode patients
and 297 healthy controls. Moreover, the observation of
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lower FA within the left IFOF among first-episode neuroleptic-naive patients compared with healthy volunteers
suggests these effects are not an artifact of antipsychotic
medication exposure.67
There are several limitations to the current study. Our
use of a self-report instrument to assess schizotypy may
allow for over or underreporting of positive and negative subclinical psychotic symptoms. In our larger sample
comprising 658 participants, however, we found high
concordance (rho > 0.80) between several measures of
subclinical psychosis, including the SPQ, and symptoms
assessed using a clinician administered diagnostic interview (SCID-NP) (P. DeRosse, unpublished data). While
this does not rule out the possibility of over- or underreporting, it lends support to the convergent validity of
the self-report measure. An additional limitation is that
because SPQ scores were not normally distributed, we
utilized a median split to identify high and low schizotypy groups. This approach, although maximizing our
power, may have limited our ability to detect more subtle
relationships between the level of subclinical psychotic
symptoms and imaging measures. However, supplementary analyses comparing 3 groups (high, medium, and low
SPQ) revealed results nearly identical to those obtained
using 2 groups. Another potential weakness of the current study is the observed sex difference between the high
and low schizotypy groups. Although we included sex as
a covariate in our analyses, to ensure that the sex difference was not driving the result we conducted ancillary
analyses demonstrating that this did not contribute to
the observed findings. Finally, it should also be noted
that tractography measures do not map directly onto the
brain regions examined using FreeSurfer and thus, we are
limited in our interpretation across imaging modalities.
In sum, the present study provided evidence for a link
between psychometric schizotypy and a range of structural and DTI-derived measures encompassing frontotemporal regions in otherwise healthy adults without the
confound of antipsychotic medications. These findings
contribute to a growing literature suggesting that psychosis can be examined along a continuum of severity and
suggest that this continuum may relate to subtle variation
in brain structure and function. Moreover, results suggest
that some frontal regions, at least at the gross anatomic
level, may serve as a compensatory mechanism that may
be relevant to the distinction between subclinical and
clinically significant psychotic symptoms.
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